Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Day One Biopharmaceuticals, Inc. (DAWN) Receiveable Turnover data is not available.
| Income Statement Financials | |
-- |
|
$-188.92M |
|
-- |
|
-- |
|
$206.06M |
|
$-206.06M |
|
$17.15M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-188.92M |
|
$-206.06M |
|
$-205.68M |
|
79.77M |
|
79.77M |
|
$-2.37 |
|
$-2.37 |
|
| Balance Sheet Financials | |
$375.27M |
|
$0.21M |
|
$0.77M |
|
$376.05M |
|
$29.51M |
|
-- |
|
-- |
|
$29.51M |
|
$346.54M |
|
$346.54M |
|
$346.54M |
|
87.23M |
|
| Cash Flow Statement Financials | |
$-146.85M |
|
$128.38M |
|
$164.00M |
|
$85.26M |
|
$230.78M |
|
$145.52M |
|
$39.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-147.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-54.52% |
|
-54.52% |
|
-50.24% |
|
-54.52% |
|
$3.97 |
|
$-1.84 |
|
$-1.84 |
|